.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Indeed, a five-year-old girl from Rajsamand recently completed a remarkable pediatric GBS recovery in Udaipur. Initially, she presented with severe bilateral leg weakness. Consequently, doctors quickly diagnosed her with Guillain-Barré Syndrome (GBS). This condition causes the body's immune system to attack peripheral nerves. Therefore, she required urgent medical intervention.
Initially, clinicians performed a tracheostomy to manage her failing respiratory system. Additionally, they placed her on prolonged ventilator support in the PICU. Specifically, her critical care lasted nearly 80 days. Furthermore, she received five doses of intravenous immunoglobulin (IVIG) therapy. This crucial treatment helps neutralize harmful autoantibodies. However, each vial of IVIG costs about Rs 40,000. Consequently, the total medicine cost reached nearly Rs 2 lakh.
Fortunately, the Mukhyamantri Ayushman Arogya (MAA) Yojana covered her entire medical expenditure of Rs 5.31 lakh. Moreover, this scheme provides vital financial relief for vulnerable families. Furthermore, physical therapists provided intensive physiotherapy to aid muscle rehabilitation. Physicians also provided free, protein-rich nutrition to help her recover physical strength. Finally, after sustained multidisciplinary efforts, she made a full recovery. Subsequently, doctors discharged the healthy child on May 31.
Q1: What is Guillain-Barré Syndrome (GBS) and how does it affect children?
Guillain-Barré Syndrome is a rare, acute autoimmune disorder. Specifically, the body's immune system attacks peripheral nerves. Consequently, this causes muscle weakness and severe respiratory distress.
Q2: What are the primary medical therapies used for severe pediatric GBS?
Typically, clinicians administer intravenous immunoglobulin (IVIG) to halt the immune attack. Additionally, supportive therapies like ventilation and physiotherapy are critical.
Q3: How long does recovery from severe pediatric GBS usually take?
Symptom recovery timelines vary. However, patients with severe disease often require several months of therapy. Fortunately, most pediatric patients eventually achieve complete recovery.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A five-year-old girl in Udaipur successfully recovered from Guillain-Barré Syndrome after 90 days of critical PICU care, tracheostomy, and IVIG therapy....
3 months ago
A new case study illuminates how functional connectivity changes drive recovery from pure alexia following posterior cerebral artery infarction. Functional reorganization supports reading recovery despite permanent structural tract disconnection, highlighting key implications for stroke rehabilitation.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
